CORC

浏览/检索结果: 共5条,第1-5条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Efficacy and safety of ranibizumab 0.5 mg in Chinese patients with visual impairment due to diabetic macular edema: results from the 12-month REFINE study 期刊论文
2019, 卷号: 257, 期号: 3, 页码: 529-541
作者:  Li, Xiaoxin;  Dai, Hong;  Li, Xiaorong;  Han, Mei;  Li, Jun
收藏  |  浏览/下载:174/0  |  提交时间:2020/01/03
Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial 期刊论文
2017, 卷号: 18, 期号: 3, 页码: 371-383
作者:  Zhang, Pin;  Sun, Tao;  Zhang, Qingyuan;  Yuan, Zhongyu;  Jiang, Zefei
收藏  |  浏览/下载:12/0  |  提交时间:2020/01/04
Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients 期刊论文
2016, 卷号: 9, 期号: 1, 页码: 68
作者:  Zhang, Pin;  Tong, Zhongsheng;  Tian, Fuguo;  Wang, Yongsheng;  Yang, Junlan
收藏  |  浏览/下载:7/0  |  提交时间:2020/01/04
Phase II clinical studies of UTD1, an epothilone analog, in metastatic breast cancer 期刊论文
2014, 卷号: 32, 期号: 15
作者:  Xu, Binghe;  Zhang, Pin;  Tong, Zhongsheng;  Tian, Fuguo;  Wang, Yongsheng
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/13
Phase II clinical studies of UTD1, an epothilone analog, in metastatic breast cancer 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2014-05-20
作者:  Xu, Binghe;  Zhang, Pin;  Tong, Zhongsheng;  Tian, Fuguo;  Wang, Yongsheng
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/13


©版权所有 ©2017 CSpace - Powered by CSpace